International Biotechnology Trust’s Juno Therapeutics, Inc. JUNO Stock Holding History

International Biotechnology Trust’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-50,000	Closed	-$2.28M	–	73
2017 Q4	$2.28M	Sell	50,000 -13,000	-21%	-$648K	0.81%	37
2017 Q3	$2.82M	Buy	+63,000	New	+$2.15M	1.1%	29

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

International Biotechnology Trust's JUNO Position: Q1 2018 in Review

International Biotechnology Trust sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 50,000 shares — an estimated $2.28M sold.

International Biotechnology Trust first reported a position in JUNO in Q3 2017 and held it in 2 quarters. The position peaked at $2.82M in Q3 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

International Biotechnology Trust reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
International Biotechnology Trust sold 50,000 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $2.28M.
International Biotechnology Trust first reported a position in Juno Therapeutics, Inc. in Q3 2017 and held it in 2 quarters.
International Biotechnology Trust's Juno Therapeutics, Inc. position peaked at $2.82M in Q3 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on International Biotechnology Trust's 13F filing for Q1 2018, filed 15 May 2018.